Adage Capital Partners Gp, L.L.C. Abb Vie Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

  • $56.4 Billion
  • Q2 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Abb Vie Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,618,841 shares of ABBV stock, worth $373 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
1,618,841
Previous 1,798,733 10.0%
Holding current value
$373 Million
Previous $377 Million 20.27%
% of portfolio
0.53%
Previous 0.73%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$170.16 - $206.27 $30.6 Million - $37.1 Million
-179,892 Reduced 10.0%
1,618,841 $300 Million
Q1 2025

May 15, 2025
BUY
$169.2 - $216.66 $11.7 Million - $15 Million
69,368 Added 4.01%
1,798,733 $377 Million
Q4 2024

Feb 14, 2025
BUY
$164.99 - $203.87 $11.8 Million - $14.6 Million
71,582 Added 4.32%
1,729,365 $307 Million
Q3 2024

Nov 14, 2024
BUY
$163.84 - $199.33 $38.9 Million - $47.3 Million
237,503 Added 16.72%
1,657,783 $327 Million
Q2 2024

Aug 14, 2024
SELL
$154.79 - $180.76 $153 Million - $178 Million
-986,865 Reduced 41.0%
1,420,280 $244 Million
Q1 2024

May 15, 2024
BUY
$159.82 - $182.1 $4.46 Million - $5.08 Million
27,904 Added 1.17%
2,407,145 $438 Million
Q4 2023

Feb 14, 2024
BUY
$137.6 - $154.97 $50.1 Million - $56.5 Million
364,424 Added 18.09%
2,379,241 $369 Million
Q3 2023

Nov 14, 2023
BUY
$133.59 - $154.65 $66.7 Million - $77.2 Million
498,978 Added 32.92%
2,014,817 $300 Million
Q2 2023

Aug 14, 2023
BUY
$132.51 - $164.9 $61.8 Million - $76.9 Million
466,069 Added 44.4%
1,515,839 $204 Million
Q1 2023

May 15, 2023
SELL
$144.61 - $166.54 $20.4 Million - $23.5 Million
-141,253 Reduced 11.86%
1,049,770 $167 Million
Q4 2022

Feb 14, 2023
SELL
$138.31 - $165.87 $78 Million - $93.5 Million
-563,623 Reduced 32.12%
1,191,023 $193 Million
Q3 2022

Nov 14, 2022
BUY
$134.21 - $153.93 $18.9 Million - $21.6 Million
140,475 Added 8.7%
1,754,646 $235 Million
Q2 2022

Aug 15, 2022
SELL
$137.62 - $174.96 $83.5 Million - $106 Million
-606,900 Reduced 27.32%
1,614,171 $247 Million
Q1 2022

May 16, 2022
BUY
$131.98 - $163.75 $31.3 Million - $38.8 Million
237,200 Added 11.96%
2,221,071 $360 Million
Q4 2021

Feb 14, 2022
BUY
$107.43 - $135.93 $57.3 Million - $72.5 Million
533,700 Added 36.8%
1,983,871 $269 Million
Q3 2021

Nov 15, 2021
SELL
$106.4 - $120.78 $72.9 Million - $82.8 Million
-685,440 Reduced 32.1%
1,450,171 $156 Million
Q2 2021

Aug 16, 2021
SELL
$105.21 - $117.21 $4.86 Million - $5.42 Million
-46,200 Reduced 2.12%
2,135,611 $241 Million
Q1 2021

May 17, 2021
SELL
$102.3 - $112.62 $19.1 Million - $21 Million
-186,800 Reduced 7.89%
2,181,811 $236 Million
Q4 2020

Feb 16, 2021
SELL
$80.49 - $108.67 $28.1 Million - $37.9 Million
-349,100 Reduced 12.85%
2,368,611 $254 Million
Q3 2020

Nov 16, 2020
BUY
$85.91 - $100.83 $59.7 Million - $70.1 Million
695,400 Added 34.39%
2,717,711 $238 Million
Q2 2020

Aug 14, 2020
BUY
$73.37 - $98.18 $148 Million - $199 Million
2,022,311 New
2,022,311 $199 Million
Q4 2019

Feb 14, 2020
SELL
$72.13 - $90.25 $74.8 Million - $93.6 Million
-1,037,161 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$62.98 - $75.72 $22.9 Million - $27.6 Million
-364,201 Reduced 25.99%
1,037,161 $78.5 Million
Q2 2019

Aug 14, 2019
BUY
$65.7 - $83.98 $92.1 Million - $118 Million
1,401,362 New
1,401,362 $102 Million
Q1 2019

May 15, 2019
SELL
$77.14 - $90.79 $30 Million - $35.3 Million
-388,962 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$77.85 - $96.01 $9.05 Million - $11.2 Million
-116,300 Reduced 23.02%
388,962 $35.9 Million
Q3 2018

Nov 14, 2018
SELL
$88.91 - $98.84 $45.5 Million - $50.5 Million
-511,400 Reduced 50.3%
505,262 $47.8 Million
Q2 2018

Aug 14, 2018
SELL
$89.78 - $106.23 $94.5 Million - $112 Million
-1,052,661 Reduced 50.87%
1,016,662 $94.2 Million
Q1 2018

May 15, 2018
SELL
$92.01 - $123.21 $9.25 Million - $12.4 Million
-100,545 Reduced 4.63%
2,069,323 $196 Million
Q4 2017

Feb 14, 2018
SELL
$89.56 - $98.21 $32.6 Million - $35.7 Million
-363,500 Reduced 14.35%
2,169,868 $210 Million
Q3 2017

Nov 14, 2017
BUY
$69.85 - $89.22 $177 Million - $226 Million
2,533,368
2,533,368 $225 Million

Others Institutions Holding ABBV

# of Institutions
4,295
Shares Held
1.3B
Call Options Held
16.1M
Put Options Held
10.9M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $407B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email